J4 ›› 2011, Vol. 37 ›› Issue (1): 163-167.

• 基础研究 • 上一篇    下一篇

化疗后乳腺癌组织中干细胞微球体的分离、培养及鉴定

董华英|吴诚义|陈元文   

  1. 重庆医科大学附属第一医院内分泌外科|重庆 400016
  • 收稿日期:2010-06-30 出版日期:2011-01-28 发布日期:2011-01-28
  • 通讯作者: 吴诚义(Tel:023-89011192,E-mail:NFMWK1192@hospital-cqmu.com) E-mail:NFMWK1192@hospital-cqmu.com
  • 作者简介:董华英(1977-)|男|河北省邢台市人|主治医师|在读医学博士|主要从事乳腺癌的基础和临床研究。
  • 基金资助:

    重庆市卫生局医学科研计划项目资助课题(06-2-028)

Isolation,culture and identification of microspheres in breast cancer stem cells after neoadjuvant chemotherapy

DONG Hua-ying,WU Cheng-yi,CHEN Yuan-wen   

  1. Department of Endocrine Surgery,Frist Affiliated Hospital,Chongqing Medical University,Chongqing 400016,China
  • Received:2010-06-30 Online:2011-01-28 Published:2011-01-28

摘要:

目的:对从接受新辅助化疗的乳腺癌患者的乳腺癌组织中分离出的化疗微球体(CMSs)进行培养和鉴定,为获取乳腺癌干细胞的新方法的建立提供理论依据。方法:①将获得的CMSs接种在添加生长因子的DMEM/F12培养基中,观察CMSs的生长情况;②通过单克隆形成实验检测化疗微球体细胞(CMSDCs)的克隆形成和自我更新能力;③CMSDCs贴壁培养在含5%胎牛血清的DMEM/F12培养基中,观察其分化能力;④免疫细胞化学检测CMSDCs及其分化细胞CK14、CK18和CK19的表达;⑤流式细胞术(FCM)检测CMSDCs及其分化细胞中ALDH1+细胞的含量;⑥ 构建NOD/SCID小鼠移植瘤模型,观察CMSDCs的致瘤能力。结果:CMSs在无血清培养基中继续呈球状生长,3 d后球体表面出现坏死的细胞层;CMSDCs可以连续传代形成新的CMSs,新生球体折光性强,表面无坏死层;在添加血清的培养基中的CMSDCs可以分化产生梭形的单层细胞;CMSDCs表达乳腺干细胞标记物CK19,不表达分化标记物CK14和CK18;CMSDCs和分化细胞中ALDH1+细胞的比例分别为为17.41%~23.57%和0.50%~1.28%;103个CMSDCs即可在NOD/SCID小鼠体内形成与原发肿瘤性质相同的移植瘤。结论:CMSs富含乳腺癌干细胞,与悬浮培养所获得的乳腺癌干细胞微球体类似,提示从化疗后的乳腺癌组织中分离癌干细胞微球体可能成为乳腺癌干细胞获取的新途径。

关键词: 乳腺肿瘤;肿瘤干细胞;乳腺癌干细胞微球体;培养液, 无血清;细胞鉴定

Abstract:

Abstract:Objective To culture and identify chemotherapy microspheres (CMSs) isolated from tumor tissues of breast cancer patients after receiving neoadjuvant chemotherapy and provide the theoretical basis for a new method to obtain breast cancer stem cells. Methods After CMSs were isolated from   the breast cancer tissues,the experiments were conducted as follows:① CMSs were plated in DMEM/F12 media containing growth factors and the growth process of CMSs was observed;② Sphere formation assay was performed to determine the self-renewal ability of chemotherapy microspheres-derived cells (CMSDCs);③ The differentiation ability of CMSDCs was observed by culturing them in DMEM/F12 containing 5% fetal bovine serum media;④ The expressions of CK14,CK18 and CK19 of CMSDCs and their differentiated cells were detected by immunocytochemistry;⑤ The ratios of ALDH1+ cells of CMSDCs and their differentiated cells were evaluated by flow cytometry (FCM);⑥ The CMSDCs were implanted into NOD/SCID mice to assess their tumorigenic potential. Results The CMSs could continue to grow in serum-free media and the necrotic cells were distributed over the surface layer of the CMSs after 3 d;The CMSDCs could form new CMSs with strong refraction by serial sphere formation assay;The CMSDCs could differentiate to monolayer of spindle-shaped cells in the media  supplemented with serum;The CMSDCs expressed the breast stem cell marker  CK19,but not CK14 and 18,which marked the myoepithelial and luminal cells,respectively;The ratio of ALDH1+ cells of the CMSDCs accounted for 17.41%-23.57% of all the cells,but which of their differented cells accounted for only 0.50%-1.28% of the total cells;New tumor identical with the primary tumors formed when 103 cells were injected into the mammary fat pad of NOD/SCID mice. Conclusion The CMSs isolated from tumor tissues are rich in breast cancer stem cells and similar to the mammospheres obtained by the suspension culture. It indicats that the isolation of the microspheres in breast cancer stem cells after neoadjuvant chemotherapy may be a new method to obtain breast cancer stem cells.

Key words: breast neoplasms;tumor stem cells;microspheres in breast cancer stem cells;culture media,serum-free;cell identification

中图分类号: 

  • R737.9